Beurs gesloten -
NSE India S.E.
13:43:52 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.447
INR
|
-1,32%
|
|
-2,64%
|
+16,12%
|
Fiscaal tijdperk: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
426.134
|
340.917
|
657.346
|
821.377
|
726.839
|
1.168.535
|
-
|
-
|
Bedrijfswaarde
1 |
463.108
|
359.042
|
658.708
|
810.334
|
716.397
|
1.208.586
|
1.111.133
|
1.083.026
|
K/w-verhouding
|
27,9
x
|
22,1
x
|
27,4
x
|
32,7
x
|
26
x
|
29,3
x
|
25,1
x
|
23,1
x
|
Dividendrendement
|
0,57%
|
0,71%
|
0,61%
|
0,49%
|
0,94%
|
0,58%
|
0,68%
|
0,69%
|
Marktkapitalisatie/omzet
|
2,6
x
|
1,99
x
|
3,43
x
|
3,77
x
|
3,19
x
|
4,69
x
|
4,18
x
|
3,83
x
|
Bedrijfswaarde/omzet
|
2,83
x
|
2,1
x
|
3,44
x
|
3,72
x
|
3,15
x
|
4,69
x
|
3,97
x
|
3,55
x
|
Bedrijfswaarde/EBITDA
|
15
x
|
11,2
x
|
15,5
x
|
17,8
x
|
14,3
x
|
19,2
x
|
16
x
|
14,2
x
|
Bedrijfswaarde/FCF
|
34,8
x
|
14,4
x
|
21,1
x
|
29,1
x
|
29,9
x
|
33,3
x
|
33,2
x
|
26,1
x
|
FCF Yield
|
2,87%
|
6,95%
|
4,74%
|
3,43%
|
3,35%
|
3,01%
|
3,01%
|
3,84%
|
Price to Book
|
2,7
x
|
2,16
x
|
3,59
x
|
3,94
x
|
3,11
x
|
4,38
x
|
3,85
x
|
3,39
x
|
Aantal aandelen (in duizenden)
|
805.699
|
806.235
|
806.460
|
806.814
|
807.151
|
807.446
|
-
|
-
|
Referentieprijs
2 |
528,9
|
422,8
|
815,1
|
1.018
|
900,5
|
1.447
|
1.447
|
1.447
|
Datum van publicatie
|
22-05-19
|
15-05-20
|
14-05-21
|
10-05-22
|
12-05-23
|
10-05-24
|
-
|
-
|
Fiscaal tijdperk: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
163.624
|
171.320
|
191.596
|
217.633
|
227.531
|
257.741
|
279.875
|
305.044
|
EBITDA
1 |
30.973
|
32.060
|
42.524
|
45.528
|
50.270
|
62.910
|
69.544
|
76.040
|
Bedrijfsresultaat (EBIT)
1 |
17.710
|
20.313
|
31.848
|
35.008
|
38.549
|
52.400
|
58.567
|
63.458
|
Operationele Marge
|
10,82%
|
11,86%
|
16,62%
|
16,09%
|
16,94%
|
20,33%
|
20,93%
|
20,8%
|
Resultaat voor belastingen (EBT)
1 |
20.791
|
21.782
|
32.901
|
34.933
|
40.384
|
57.019
|
64.037
|
69.761
|
Nettowinst (verlies)
1 |
15.277
|
15.465
|
24.049
|
25.168
|
28.019
|
41.216
|
46.643
|
50.809
|
Nettomarge
|
9,34%
|
9,03%
|
12,55%
|
11,56%
|
12,31%
|
15,99%
|
16,67%
|
16,66%
|
WPA
2 |
18,93
|
19,16
|
29,79
|
31,17
|
34,69
|
51,01
|
57,59
|
62,75
|
Free Cash Flow
1 |
13.311
|
24.957
|
31.255
|
27.818
|
23.971
|
33.440
|
33.432
|
41.554
|
FCF-marge
|
8,13%
|
14,57%
|
16,31%
|
12,78%
|
10,54%
|
12,96%
|
11,95%
|
13,62%
|
Kasstroomconversie (ebitda)
|
42,98%
|
77,84%
|
73,5%
|
61,1%
|
47,69%
|
53,11%
|
48,07%
|
54,65%
|
Kasstroomconversie (nettowinst)
|
87,13%
|
161,37%
|
129,97%
|
110,53%
|
85,55%
|
81,04%
|
71,68%
|
81,78%
|
Dividend per aandeel
2 |
3,000
|
3,000
|
5,000
|
5,000
|
8,500
|
8,362
|
9,848
|
9,973
|
Datum van publicatie
|
22-05-19
|
15-05-20
|
14-05-21
|
10-05-22
|
12-05-23
|
10-05-24
|
-
|
-
|
Fiscaal tijdperk: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
51.687
|
46.064
|
55.044
|
55.198
|
54.789
|
52.603
|
53.752
|
58.285
|
58.101
|
57.393
|
63.289
|
64.681
|
64.992
|
62.574
|
69.440
|
EBITDA
1 |
12.309
|
7.962
|
13.459
|
12.262
|
12.310
|
7.497
|
11.434
|
13.023
|
14.076
|
11.737
|
14.939
|
15.121
|
15.951
|
13.891
|
17.220
|
Bedrijfsresultaat (EBIT)
1 |
9.824
|
5.110
|
10.848
|
9.731
|
9.835
|
4.594
|
8.889
|
10.030
|
11.354
|
8.275
|
12.547
|
12.819
|
13.101
|
11.194
|
14.323
|
Operationele Marge
|
19,01%
|
11,09%
|
19,71%
|
17,63%
|
17,95%
|
8,73%
|
16,54%
|
17,21%
|
19,54%
|
14,42%
|
19,82%
|
19,82%
|
20,16%
|
17,89%
|
20,63%
|
Resultaat voor belastingen (EBT)
1 |
10.215
|
5.437
|
9.955
|
9.958
|
10.541
|
4.478
|
9.746
|
11.004
|
12.181
|
7.454
|
13.746
|
13.757
|
13.933
|
12.446
|
15.576
|
Nettowinst (verlies)
1 |
7.482
|
4.134
|
7.147
|
7.114
|
7.286
|
3.621
|
6.864
|
7.889
|
8.010
|
5.256
|
9.957
|
9.743
|
10.517
|
9.088
|
11.417
|
Nettomarge
|
14,47%
|
8,97%
|
12,98%
|
12,89%
|
13,3%
|
6,88%
|
12,77%
|
13,54%
|
13,79%
|
9,16%
|
15,73%
|
15,06%
|
16,18%
|
14,52%
|
16,44%
|
WPA
2 |
9,260
|
5,120
|
8,850
|
8,800
|
9,020
|
4,480
|
8,500
|
9,770
|
9,920
|
6,510
|
12,33
|
12,53
|
12,86
|
11,25
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29-01-21
|
14-05-21
|
05-08-21
|
26-10-21
|
25-01-22
|
10-05-22
|
29-07-22
|
04-11-22
|
25-01-23
|
12-05-23
|
26-07-23
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
36.974
|
18.125
|
1.363
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
-
|
-
|
11.043
|
10.443
|
55.826
|
57.403
|
85.509
|
Hefboom (schuld/ebitda)
|
1,194
x
|
0,5654
x
|
0,032
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
13.311
|
24.957
|
31.255
|
27.818
|
23.971
|
33.440
|
33.432
|
41.554
|
ROE (netto-inkomsten/eigen vermogen)
|
10,4%
|
10,1%
|
14,1%
|
12,9%
|
12,7%
|
16,2%
|
15,9%
|
15,3%
|
ROA (netto-inkomsten/totale activa)
|
6,53%
|
6,49%
|
9,85%
|
9,63%
|
9,91%
|
12,7%
|
13,2%
|
12,8%
|
Totale activa
1 |
234.120
|
238.129
|
244.072
|
261.266
|
282.821
|
325.660
|
352.486
|
397.876
|
Nettoactief per aandeel
2 |
196,0
|
196,0
|
227,0
|
258,0
|
290,0
|
330,0
|
375,0
|
427,0
|
Cashflow per aandeel
2 |
21,00
|
38,00
|
46,50
|
41,20
|
40,10
|
58,40
|
60,10
|
61,70
|
Capex
1 |
3.601
|
5.728
|
6.297
|
5.441
|
11.829
|
10.295
|
11.701
|
11.888
|
Capex/omzet
|
2,2%
|
3,34%
|
3,29%
|
2,5%
|
5,2%
|
3,99%
|
4,18%
|
3,9%
|
Datum van publicatie
|
22-05-19
|
15-05-20
|
14-05-21
|
10-05-22
|
12-05-23
|
10-05-24
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
1.447
INR Gemiddelde koersdoel
1.482
INR Spread / Gemiddelde doel +2,42% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +16,12% | 14 mld. | | +15,91% | 41,97 mld. | | +22,40% | 22,34 mld. | | +18,48% | 15,25 mld. | | +45,12% | 12,06 mld. | | -9,58% | 6,8 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +14,18% | 5,49 mld. | | +4,00% | 4,62 mld. |
Generieke geneesmiddelen
|